Ambiguous identities of drugs and people: a scoping review of opioid-related stigma

MD McCradden, D Vasileva, A Orchanian-Cheff… - International Journal of …, 2019 - Elsevier
Background Human beings have long consumed opiates and opioids for pleasure and as a
treatment for numerous ailments, most notably pain. North America is currently in the grips of …

Neuroscience-informed psychoeducation for addiction medicine: A neurocognitive perspective

H Ekhtiari, T Rezapour, RL Aupperle… - Progress in brain research, 2017 - Elsevier
Psychoeducation (PE) is defined as an intervention with systematic, structured, and didactic
knowledge transfer for an illness and its treatment, integrating emotional and motivational …

“Criminalization Causes the Stigma”: perspectives from people who use drugs

BD Scher, SD Neufeld, A Butler… - Contemporary Drug …, 2023 - journals.sagepub.com
Introduction In light of North America's persisting drug toxicity crisis, alternative drug policy
approaches such as decriminalization, legalization, regulation, and safer supply have …

[HTML][HTML] Tracing the affordances of long-acting injectable depot buprenorphine: a qualitative study of patients' experiences in Australia

A Barnett, M Savic, N Lintzeris, R Bathish… - Drug and Alcohol …, 2021 - Elsevier
Background Long-acting injectable depot buprenorphine is an important new treatment
option for the management of opioid dependence, delivering therapeutic doses in weekly or …

Drug and alcohol treatment providers' views about the disease model of addiction and its impact on clinical practice: A systematic review

AI Barnett, W Hall, CL Fry… - Drug and alcohol …, 2018 - Wiley Online Library
Issues Addiction treatment providers' views about the disease model of addiction (DMA),
and their contemporary views about the brain disease model of addiction (BDMA), remain …

Can a new formulation of opiate agonist treatment alter stigma?: Place, time and things in the experience of extended-release buprenorphine depot

C Treloar, K Lancaster, S Gendera, T Rhodes… - International Journal of …, 2022 - Elsevier
Introduction Stigma has corrosive effects on all aspects of care and can undermine
individual and population health outcomes. Addiction-related stigma has implications for …

[HTML][HTML] Conceptualising hepatitis C stigma: A thematic synthesis of qualitative research

M Harris, D Guy, CA Picchio, TM White… - International Journal of …, 2021 - Elsevier
Background Stigma is an important element in the experience of living with chronic viral
hepatitis B (HBV) and C (HCV), impacting healthcare access and uptake as well as health …

Medication-assisted treatment for opioid addiction in the United States: Critique and commentary

K McElrath - Substance Use & Misuse, 2018 - Taylor & Francis
ABSTRACT In the United States, buprenorphine products (namely buprenorphine/naloxone
combination) and methadone are the primary forms of medication-assisted treatment (MAT) …

The epidemic as stigma: The bioethics of opioids

DZ Buchman, P Leece, A Orkin - The Journal of Law …, 2017 - journals.sagepub.com
In this paper, we claim that we can only seek to eradicate the stigma associated with the
contemporary opioid overdose epidemic when we understand how opioid stigma and the …

“Bed Bugs and Beyond”: An ethnographic analysis of North America's first women-only supervised drug consumption site

J Boyd, J Lavalley, S Czechaczek, S Mayer… - International Journal of …, 2020 - Elsevier
Background Attention to how women are differentially impacted within harm reduction
environments is salient amidst North America's overdose crisis. Harm reduction …